Wish you all a very happy new Year 2022. Hope that you and your organization have your goals all set and now it is time to hit each of the milestone one at a time. Hayat Pharmaceuticals Consulting (HPC) is launching into new direction where we, not only, provide technical advice, or formulate cost/time effective plans for our clients but also offer where such plans can be executed. We are putting together a suite of CDMOs and as part of this initiative, HPC has entered into collaboration with Ausun Pharma to present them in North America. Ausun Pharma is based in China and specializes in synthesis of RMs, Intermediates, APIs and formulation development services. The company has very aggressive plans to expand their business partnerships in Europe and North Ameirca and HPC would like to play instrumental role in this.

Please reach us to know more about capabilities, capacities, and offerings of Ausun Pharma.

Regards,

Umar Hayat Ph.D.

Principal,

Hayat Pharmaceutical Consulting

If we don’t put the interest of patients and our clients first, we don’t have right to exist.